Resilience Government Services, Inc.
Doing business as Nanotherapeutics Inc. Part of Resilience US Inc.
- UEI
- GC2RFAZK8G64
- CAGE
- 3GQS9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 325412 Pharmaceutical Preparation Manufacturing Primary
- 325414 Biological Product (except Diagnostic) Manufacturing
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Corporate family
-
-
Resilience US Inc.
Parent
DWAQWC7R2DN8
- Resilience Government Services, Inc. GC2RFAZK8G64
-
Resilience US Inc.
Parent
DWAQWC7R2DN8
- SAM.gov registration date
- Website
- resilience.com
- Founded
- 2020
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of LNA14 analytical methods and upstream and downstream processes for manufacturing, and scale-up… | National Institute of Allergy and Infectious Diseases | $799,780 | |
| Drug substance (DS) process validation, drug product (DP) process validation, clinical development phase 3, and… | ACC Aberdeen Proving Ground | $4,278,565 | |
| DS process characterization | ACC Aberdeen Proving Ground | $4,459,366 | |
| Clinical development phase 2 study | ACC Aberdeen Proving Ground | $93,029,233 | |
| "covid-19" MAB sponsorship prototype | ACC Aberdeen Proving Ground | $31,048,125 |
About Resilience Government Services, Inc.
Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., is a technology focused biomanufacturing company dedicated to broadening access to complex medicines. Founded in 2020, Resilience aims to build a sustainable network of high tech, end to end manufacturing solutions to ensure the medicines of today and tomorrow are reliably supplied.
Through past federal contract awards, Resilience Government Services has provided a range of goods and services related to chemical and biological defense programs, medical countermeasure development, and pharmaceutical manufacturing. As a prime contractor, Resilience has conducted clinical trials, process development and validation, storage and stability testing, prototype development, and manufacturing scale-up across various task orders and contracts with the Department of Defense, specifically the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense, as well as the Department of Health and Human Services National Institutes of Health. Resilience has provided deliverables spanning early stage research through late stage product development, with the goal of achieving FDA licensure for medical countermeasures against biological threats and COVID-19. No set aside designations were indicated on the prime contract awards.
Resilience Government Services currently holds two active Indefinite Delivery Vehicles from the Department of the Army's Acquisition Support Center. A $5.7 million Other Transaction IDIQ aims to transfer existing capabilities to Resilience to demonstrate the provision of medical countermeasures. A $249 million single-award Indefinite Delivery Contract provides an acquisition vehicle for FDA-approved products supporting chemical and biological defense programs. Associated task orders under the IDC advance development and testing of a monoclonal antibody countermeasure through clinical trials and regulatory approval processes.
Contract vehicles
Quick answers
What is Resilience Government Services, Inc.'s UEI?
Resilience Government Services, Inc.'s Unique Entity ID (UEI) in SAM.gov is GC2RFAZK8G64.
What is Resilience Government Services, Inc.'s CAGE code?
Resilience Government Services, Inc.'s CAGE code is 3GQS9.
What is Resilience Government Services, Inc.'s primary NAICS code?
Resilience Government Services, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Is Resilience Government Services, Inc. registered in SAM.gov?
Resilience Government Services, Inc.'s SAM.gov registration expired on February 20, 2026.
Who is Resilience Government Services, Inc.'s parent company?
Resilience Government Services, Inc. is part of Resilience US Inc.
Which contract vehicles does Resilience Government Services, Inc. hold?
Resilience Government Services, Inc. holds a place on 2 federal contract vehicles, including FFMN and Preclinical Services for Biopharmaceutical Product Development.
What is Resilience Government Services, Inc.'s most recent federal award?
Resilience Government Services, Inc.'s most recent federal contract award is Development of LNA14 analytical methods and upstream and downstream processes for manufacturing, and scale-up… (75N93023F00001), from National Institute of Allergy and Infectious Diseases, on August 28, 2023.
On GovTribe
See Resilience Government Services, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors